Solventum Corporation (SOLV) Stock
SOLV Key Statistics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
CEO: Bryan C. Hanson. Company website
SOLV — Frequently Asked Questions
What is the SOLV stock price today?
Solventum Corporation (SOLV) trades at $88.84, up 1.50% on the day, as of Sep 20, 2026 15:01 UTC.
What is Solventum Corporation's market cap?
Solventum Corporation has a market capitalisation of $15.38B, calculated from the live SOLV share price and shares outstanding.
What is the P/E ratio of SOLV?
SOLV trades at a trailing P/E of 10.85, from earnings per share of $8.19 over the last twelve months.
How much revenue does Solventum Corporation make?
Solventum Corporation generated revenue of $8.31B over the trailing twelve months, which puts the stock at 1.85 times sales.
What is the 52-week range for SOLV?
SOLV has traded between $62.38 and $94.16 over the past 52 weeks, and the last price is 5.6% below that high.
Is Solventum Corporation profitable?
Yes. Solventum Corporation keeps 17.26% of revenue as net income over the trailing twelve months.
What is the analyst price target for SOLV?
Wall Street analysts rate SOLV Buy, with an average price target of $91.22, 2.7% above the current price.
What sector is Solventum Corporation in?
Solventum Corporation is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of Solventum Corporation?
Bryan C. Hanson is the chief executive of Solventum Corporation, which employs 20,584 people.
Where can I track SOLV in real time?
QFI Terminal shows SOLV with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See SOLV live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open SOLV in Terminal See plans